Siemens Healthineers announces market introduction of the teamplay digital health platform. With the teamplay digital health platform Siemens Healthineers paves the way for healthcare providers' digital transformation - facilitating easy access to solutions for operational, clinical & shared decision support.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the HealthSuite System of Engagement, an integrated, modular set of standards-based capabilities that support the development of digital health propositions, including new capabilities for cloud-based managed AI workflow and DICOM interoperability.

AI-Pathway Companion Prostate Cancer(2), a digital companion from Siemens Healthineers to support clinical decision-making, has recently received the CE mark for use in the clinical pathway of prostate cancer, the second most common cancer (after lung cancer) affecting males worldwide.(3)

Highland Marketing will be returning to Digital Health Rewired this year, where it will be sponsoring the café that has been created with an expanded exhibition area.

Digital Health Rewired launched as a two-day leadership summit, conference and exhibition in 2019 and is returning to Olympia London on 3 and 4 March with a bigger programme and more exhibitors; many of them Highland Marketing clients.

Better is attending this year's Digital Health Rewired conference and exhibition at Olympia London alongside Taunton and Somerset NHS Foundation Trust, which is using its open platform to develop an electronic patient record.

The company will have a stand and a speaking slot at the leading industry event, and will use the opportunity to discuss the best way for trusts to make a success of the 'best of breed' approach to EPR with the UK health tech community.

Boehringer Ingelheim and Carebox Healthcare Solutions announced the recent launch of MyStudyWindow, a digital platform empowering patients, families, caregivers, and doctors to learn about Boehringer Ingelheim's studies by offering information in an easy to access and understandable way.

Stockholm-based AlgoDx, which focuses on supporting disease detection and prediction with machine learning algorithms, has closed a 6 MSEK (600 000 EUR) seed round led by Nascent Invest with participation from angel investors Fredrik Sjödin and Tomas Mora-Morrison, co-founder of Cambio Healthcare Systems.